Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
J. Public Health Africa (Online)
;
14(5): 1-12, 2023.
Artículo
en Inglés
| AIM
| ID: biblio-1435811
ABSTRACT
By May 30th, 2022, there were 526,182,662 confirmed COVID-19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3,143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, a mapping of vaccine acceptance and hesitancy across geographies and demographics, increased stakeholder communication, and effective community engagement are needed.
Asunto(s)
Texto completo:
Disponible
Índice:
AIM (África)
Asunto principal:
Programas de Inmunización
/
Prevención de Enfermedades
/
Vacunas contra la COVID-19
/
COVID-19
/
Vacilación a la Vacunación
Idioma:
Inglés
Revista:
J. Public Health Africa (Online)
Año:
2023
Tipo del documento:
Artículo
Institución/País de afiliación:
Department of Infectious Disease and Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom/GB
/
Nigeria Solidarity Support Fund, Management Department, Lagos, Nigeria/NG
/
Nigeria Solidarity Support Fund, Programs Department, Lagos, Nigeria/NG
Similares
MEDLINE
...
LILACS
LIS